Stock listing
SMMT Stock Price, News, Filings & Events — Summit Therapeutics Inc.
Selected listing: SMMT · BIVA · MXN · MX
This page tracks Summit Therapeutics Inc.'s SMMT:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SMMT:BIVA. SMMT:BIVA is the stock-level entry point for investors researching Summit Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. With a market capitalization of approximately $10.6 billion, the company focuses on developing innovative therapeutics for various medical conditions. Summit Therapeutics aims to address unmet medical needs through its advanced research and development initiatives.
- Ticker
- SMMT:BIVA
- Asset type
- Stock
- Market cap
- $14.00B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- BIVA
- Currency
- MXN
Summit Therapeutics Inc. SMMT:BIVA stock context
This page tracks Summit Therapeutics Inc.'s SMMT:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SMMT:BIVA. SMMT:BIVA is the stock-level entry point for investors researching Summit Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. With a market capitalization of approximately $10.6 billion, the company focuses on developing innovative therapeutics for various medical conditions. Summit Therapeutics aims to address unmet medical needs through its advanced research and development initiatives.
Latest news from Summit Therapeutics Inc.
Updated HARMONi Data Presented at WCLC 2026 Demonstrate Consistent Overall Survival Results with Ivonescimab Plus Chemotherapy in Western and Asian Patients
September 15, 2026
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study Conducted in China
September 13, 2026
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
August 25, 2026
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for First-Line Treatment of Patients with Squamous Non-Small Cell Lung Cancer
August 12, 2026
Summit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer
August 5, 2026
Summit Therapeutics Inc. earnings calls
Summit Therapeutics Inc. (SMMT) Q2 2026 Earnings Call
July 23, 2026 · Replay with transcript and chapters
Summit Therapeutics Inc. (SMMT) Q4 2025 Earnings Call
February 23, 2026 · Replay with transcript and chapters
Summit Therapeutics Inc. (SMMT) Q3 2025 Earnings Call
October 20, 2025 · Replay with transcript and chapters
Summit Therapeutics Inc. (SMMT) Q1 2025 Earnings Call
May 1, 2025 · Replay with transcript and chapters
Summit Therapeutics Inc. (SMMT) Q4 2024 Earnings Call
February 24, 2025 · Replay with transcript and chapters
Summit Therapeutics Inc. (SMMT) Q3 2024 Earnings Call
October 30, 2024 · Replay with transcript and chapters
Research Summit Therapeutics Inc.
Summit Therapeutics Inc. investor report
Review AI stock analysis and investor report context for SMMT:BIVA.
Summit Therapeutics Inc. company profile
View the public company page for Summit Therapeutics Inc. on 6ix.
Summit Therapeutics Inc. news
Read company news and market updates connected to Summit Therapeutics Inc..
Summit Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Summit Therapeutics Inc..
Alternate listings
SMMT:NASDAQ
US · USD
Alternate listing for Summit Therapeutics Inc.; the primary context on this page is SMMT:BIVA.
SMMT:BMV
MX · MXN
Alternate listing for Summit Therapeutics Inc.; the primary context on this page is SMMT:BIVA.
SMMT:BOATS
US · USD
Alternate listing for Summit Therapeutics Inc.; the primary context on this page is SMMT:BIVA.